Kyverna Therapeutics Presents Full One-Year Registrational Data for Miv-cel in Stiff Person Syndrome

Article summary

Kyverna Therapeutics has presented its full one-year registrational data set for miv-cel, demonstrating sustained clinical benefit in patients with stiff person syndrome.